CD274 and neoplasm: PD-1 expression on tumor-infiltrating lymphocytes interacts with PD-L1 expressed on tumors and/or immune cells in the tumor microenvironment (TME), thus attenuating effector T cell responses and enabling tumors to escape immune attack.